BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36521353)

  • 1. Ten-year conditional probability of survival for patients with ovarian cancer: A new metric tailored to Long-term survivors.
    Kahn R; Filippova O; Gordhandas S; An A; Straubhar AM; Zivanovic O; Gardner GJ; O'Cearbhaill RE; Tew WP; Grisham RN; Sonoda Y; Long Roche K; Abu-Rustum NR; Chi DS
    Gynecol Oncol; 2023 Feb; 169():85-90. PubMed ID: 36521353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditional Probability of Survival and Prognostic Factors in Long-Term Survivors of High-Grade Serous Ovarian Cancer.
    Fabbro M; Colombo PE; Leaha CM; Rouanet P; Carrère S; Quenet F; Gutowski M; Mourregot A; D'Hondt V; Coupier I; Vendrell J; Vilquin P; Pujol P; Solassol J; Mollevi C
    Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32764409
    [No Abstract]   [Full Text] [Related]  

  • 3. Characteristics of Long-Term Survivors of Epithelial Ovarian Cancer.
    Cress RD; Chen YS; Morris CR; Petersen M; Leiserowitz GS
    Obstet Gynecol; 2015 Sep; 126(3):491-497. PubMed ID: 26244529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platinum-based adjuvant chemotherapy on moderate- and high-risk stage I and II epithelian ovarian cancer patients. Long-term single institution experience and literature review.
    García-Sáenz JA; Custodio A; Casado A; Vidart JA; Coronado PJ; Martín M; López-Tarruella S; Puente J; Fernández C; Díaz-Rubio E
    Clin Transl Oncol; 2011 Feb; 13(2):121-32. PubMed ID: 21324801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and prognostic inflection points among long-term survivors of advanced epithelial ovarian cancer.
    Son JH; Kong TW; Paek J; Song KH; Chang SJ; Ryu HS
    Int J Gynaecol Obstet; 2017 Dec; 139(3):352-357. PubMed ID: 28857180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What proportion of patients with stage 3 ovarian cancer are potentially cured following intraperitoneal chemotherapy? Analysis of the long term (≥10 years) survivors in NRG/GOG randomized clinical trials of intraperitoneal and intravenous chemotherapy in stage III ovarian cancer.
    Pitiyarachchi O; Friedlander M; Java JJ; Chan JK; Armstrong DK; Markman M; Herzog TJ; Monk BJ; Backes F; Secord AA; Bonebrake A; Rose PG; Tewari KS; Lentz SS; Geller MA; Copeland LJ; Mannel RS
    Gynecol Oncol; 2022 Sep; 166(3):410-416. PubMed ID: 35835612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conditional survival for long-term colorectal cancer survivors in the Netherlands: who do best?
    van Erning FN; van Steenbergen LN; Lemmens VEPP; Rutten HJT; Martijn H; van Spronsen DJ; Janssen-Heijnen MLG
    Eur J Cancer; 2014 Jul; 50(10):1731-1739. PubMed ID: 24814358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.
    Lawrie TA; Winter-Roach BA; Heus P; Kitchener HC
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD004706. PubMed ID: 26676202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study.
    Rosenthal AN; Fraser LSM; Philpott S; Manchanda R; Burnell M; Badman P; Hadwin R; Rizzuto I; Benjamin E; Singh N; Evans DG; Eccles DM; Ryan A; Liston R; Dawnay A; Ford J; Gunu R; Mackay J; Skates SJ; Menon U; Jacobs IJ;
    J Clin Oncol; 2017 May; 35(13):1411-1420. PubMed ID: 28240969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of 10-year survivors of high-grade serous ovarian carcinoma.
    Dao F; Schlappe BA; Tseng J; Lester J; Nick AM; Lutgendorf SK; McMeekin S; Coleman RL; Moore KN; Karlan BY; Sood AK; Levine DA
    Gynecol Oncol; 2016 May; 141(2):260-263. PubMed ID: 26968641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of carbohydrate antigens in advanced-stage ovarian carcinomas and their metastases-A clinicopathologic study.
    Davidson B; Gotlieb WH; Ben-Baruch G; Kopolovic J; Goldberg I; Nesland JM; Berner A; Bjåmer A; Bryne M
    Gynecol Oncol; 2000 Apr; 77(1):35-43. PubMed ID: 10739688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Survival Among Histological Subtypes in Advanced Epithelial Ovarian Cancer: Population-Based Study Using the Surveillance, Epidemiology, and End Results Database.
    Yang SP; Su HL; Chen XB; Hua L; Chen JX; Hu M; Lei J; Wu SG; Zhou J
    JMIR Public Health Surveill; 2021 Nov; 7(11):e25976. PubMed ID: 34787583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Stage III Epithelial Ovarian Cancer.
    Lei Z; Wang Y; Wang J; Wang K; Tian J; Zhao Y; Chen L; Wang J; Luo J; Jia M; Tang H; He Q; Liao Q; Yang X; Guan T; Wang L; Cui S;
    JAMA Netw Open; 2020 Aug; 3(8):e2013940. PubMed ID: 32840622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life among long-term survivors of advanced stage ovarian cancer: A cross-sectional approach.
    Lutgendorf SK; Shinn E; Carter J; Leighton S; Baggerly K; Guindani M; Fellman B; Matzo M; Slavich GM; Goodman MT; Tew W; Lester J; Moore KM; Karlan BY; Levine DA; Sood AK
    Gynecol Oncol; 2017 Jul; 146(1):101-108. PubMed ID: 28527672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of Revised FIGO Staging Classification for Cancer of the Ovary, Fallopian Tube, and Peritoneum Based on a Single Histological Type.
    Toptas T; Pestereli E; Erol O; Bozkurt S; Erdogan G; Simsek T
    Int J Gynecol Cancer; 2016 Jul; 26(6):1012-9. PubMed ID: 27206284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conditional survival in ovarian cancer: results from the SEER dataset 1988-2001.
    Choi M; Fuller CD; Thomas CR; Wang SJ
    Gynecol Oncol; 2008 May; 109(2):203-9. PubMed ID: 18329082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary malignancies in long-term ovarian cancer survivors: results of the 'Carolin meets HANNA' study.
    Woopen H; Rolf C; Braicu EI; Buttmann-Schweiger N; Barnes B; Baum J; Pietzner K; Kraywinkel K; Sehouli J
    Int J Gynecol Cancer; 2021 May; 31(5):709-712. PubMed ID: 33649156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival of Women With Type I and II Epithelial Ovarian Cancer Detected by Ultrasound Screening.
    van Nagell JR; Burgess BT; Miller RW; Baldwin L; DeSimone CP; Ueland FR; Huang B; Chen Q; Kryscio RJ; Pavlik EJ
    Obstet Gynecol; 2018 Nov; 132(5):1091-1100. PubMed ID: 30303916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditional net survival: Relevant prognostic information for colorectal cancer survivors. A French population-based study.
    Drouillard A; Bouvier AM; Rollot F; Faivre J; Jooste V; Lepage C
    Dig Liver Dis; 2015 Jul; 47(7):597-601. PubMed ID: 25911573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of socioeconomic status on long-term survival of non-localized epithelial ovarian cancer ꟷ The Extreme study.
    Baandrup L; Dehlendorff C; Hertzum-Larsen R; Hannibal CG; Kjaer SK
    Gynecol Oncol; 2021 May; 161(2):458-462. PubMed ID: 33583579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.